Ernst R. Dow
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Bioinformatics and Genomic Networks, Cytokine Signaling Pathways and Interactions, Monoclonal and Polyclonal Antibodies Research, Vestibular and auditory disorders
Most-Cited Works
- → Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution(1991)201 cited
- → Gene clustering using self-organizing maps and particle swarm optimization(2004)165 cited
- → Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes(2001)146 cited
- → Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray(2005)96 cited
- → The use of neural networks for variable selection in QSAR(1993)77 cited
- → Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab(2016)73 cited
- → Assessment of Diet‐induced Obese Rats as an Obesity Model by Comparative Functional Genomics(2008)70 cited
- → Changes in Osteoblast, Chondrocyte, and Adipocyte Lineages Mediate the Bone Anabolic Actions of PTH and Small Molecule GSK‐3 Inhibitor(2007)65 cited
- → Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways(2020)61 cited
- → IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood(2014)59 cited